These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 15155573

  • 1. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo.
    Samuel CS, Unemori EN, Mookerjee I, Bathgate RA, Layfield SL, Mak J, Tregear GW, Du XJ.
    Endocrinology; 2004 Sep; 145(9):4125-33. PubMed ID: 15155573
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. H3 relaxin demonstrates antifibrotic properties via the RXFP1 receptor.
    Hossain MA, Man BC, Zhao C, Xu Q, Du XJ, Wade JD, Samuel CS.
    Biochemistry; 2011 Mar 01; 50(8):1368-75. PubMed ID: 21229994
    [Abstract] [Full Text] [Related]

  • 4. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
    Ma J, Ma SY, Ding CH.
    Chin J Integr Med; 2017 May 01; 23(5):362-369. PubMed ID: 26956464
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo.
    Williams EJ, Benyon RC, Trim N, Hadwin R, Grove BH, Arthur MJ, Unemori EN, Iredale JP.
    Gut; 2001 Oct 01; 49(4):577-83. PubMed ID: 11559657
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
    Cofre C, Acuña MJ, Contreras O, Morales MG, Riquelme C, Cabello-Verrugio C, Brandan E.
    Biofactors; 2015 Oct 01; 41(2):111-20. PubMed ID: 25809912
    [Abstract] [Full Text] [Related]

  • 10. Collagen receptor cross-talk determines α-smooth muscle actin-dependent collagen gene expression in angiotensin II-stimulated cardiac fibroblasts.
    V H, Titus AS, Cowling RT, Kailasam S.
    J Biol Chem; 2019 Dec 20; 294(51):19723-19739. PubMed ID: 31699892
    [Abstract] [Full Text] [Related]

  • 11. Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats.
    Tsuruda T, Kato J, Hatakeyama K, Masuyama H, Cao YN, Imamura T, Kitamura K, Asada Y, Eto T.
    Cardiovasc Res; 2005 Mar 01; 65(4):921-9. PubMed ID: 15721873
    [Abstract] [Full Text] [Related]

  • 12. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.
    Taniyama Y, Morishita R, Nakagami H, Moriguchi A, Sakonjo H, Shokei-Kim, Matsumoto K, Nakamura T, Higaki J, Ogihara T.
    Circulation; 2000 Jul 11; 102(2):246-52. PubMed ID: 10889138
    [Abstract] [Full Text] [Related]

  • 13. Antifibrotic properties of relaxin: in vivo mechanism of action in experimental renal tubulointerstitial fibrosis.
    Hewitson TD, Ho WY, Samuel CS.
    Endocrinology; 2010 Oct 11; 151(10):4938-48. PubMed ID: 20826562
    [Abstract] [Full Text] [Related]

  • 14. Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats.
    Lekgabe ED, Kiriazis H, Zhao C, Xu Q, Moore XL, Su Y, Bathgate RA, Du XJ, Samuel CS.
    Hypertension; 2005 Aug 11; 46(2):412-8. PubMed ID: 15967869
    [Abstract] [Full Text] [Related]

  • 15. Nuclear Receptor Nur77 Controls Cardiac Fibrosis through Distinct Actions on Fibroblasts and Cardiomyocytes.
    Medzikovic L, Heese H, van Loenen PB, van Roomen CPAA, Hooijkaas IB, Christoffels VM, Creemers EE, de Vries CJM, de Waard V.
    Int J Mol Sci; 2021 Feb 05; 22(4):. PubMed ID: 33562500
    [Abstract] [Full Text] [Related]

  • 16. Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.
    Chow BS, Chew EG, Zhao C, Bathgate RA, Hewitson TD, Samuel CS.
    PLoS One; 2012 Feb 05; 7(8):e42714. PubMed ID: 22936987
    [Abstract] [Full Text] [Related]

  • 17. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
    Pini A, Shemesh R, Samuel CS, Bathgate RA, Zauberman A, Hermesh C, Wool A, Bani D, Rotman G.
    J Pharmacol Exp Ther; 2010 Dec 05; 335(3):589-99. PubMed ID: 20826567
    [Abstract] [Full Text] [Related]

  • 18. Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy.
    Haudek SB, Cheng J, Du J, Wang Y, Hermosillo-Rodriguez J, Trial J, Taffet GE, Entman ML.
    J Mol Cell Cardiol; 2010 Sep 05; 49(3):499-507. PubMed ID: 20488188
    [Abstract] [Full Text] [Related]

  • 19. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats.
    Li G, Xing W, Zhang M, Geng F, Yang H, Zhang H, Zhang X, Li J, Dong L, Gao F.
    Am J Physiol Heart Circ Physiol; 2018 Oct 01; 315(4):H802-H813. PubMed ID: 29957017
    [Abstract] [Full Text] [Related]

  • 20. Induction of cardiac fibrosis by angiotensin II.
    Lijnen PJ, Petrov VV, Fagard RH.
    Methods Find Exp Clin Pharmacol; 2000 Dec 01; 22(10):709-23. PubMed ID: 11346891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.